GENEVA, Sept. 24 -- THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA filed a patent application (US2026/018305) for “USING CANCER-DERIVED EXTRACELLULAR VESICLES TO PRODUCE CANCER-TARGETING ANTIBODIES AND ANTI-CANCER TREATMENTS”. With publication no. WO/2026/198268, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....